Reduced nocturnal hypoglycaemia with insulin degludec as compared to insulin glargine: results of a 2-year randomised trial in type 2 diabetes

被引：0
|
作者：
Rodbard, H. W. [1 ]
Zinman, B. [2 ]
Cariou, B. [3 ]
Philis-Tsimikas, A. [4 ]
Handelsman, Y.
Skjoth, T. V. [5 ]
Chu, P. -L. [6 ]
Mathieu, C. [7 ]
机构：
[1] Endocrine & Metab Consultants, Rockville, MD USA
[2] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5S 1A1, Canada
[3] Nantes Univ Hosp, Dept Endocrinol, Nantes, France
[4] Scripps Whittier Diabet Inst, La Jolla, CA USA
[5] Novo Nordisk A S, Soborg, Denmark
[6] Novo Nordisk Inc, Princeton, NJ USA
[7] Katholieke Univ Leuven, UZ Gasthuisberg, Louvain, Belgium
来源：
DIABETOLOGIA | 2012年 / 55卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
920
引用
收藏
页码：S378 / S378
页数：1
相关论文
共 50 条
  • [1] Reduced nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a two year trial in Type 2 diabetes
    Cariou, B.
    Rodbard, H.
    Zinman, B.
    Philis-Tsimikas, A.
    Handlesman, Y.
    Skoth, T. V.
    Chu, P-L
    Mathieu, C.
    [J]. DIABETIC MEDICINE, 2013, 30 : 55 - 55
  • [2] Physical health status and nocturnal hypoglycaemia with insulin degludec vs insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes
    Handelsman, Y.
    Cariou, B.
    Rodbard, H. W.
    Zinman, B.
    Wolden, M. L.
    Rana, A.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2013, 56 : S422 - S422
  • [3] A two year randomised trial: improved glycaemic control and lower risk of nocturnal hypoglycaemia with insulin degludec compared with insulin glargine in Type 1 diabetes
    Russell-Jones, D. L.
    Heller, S.
    Hansen, C. T.
    Chang, D.
    Bode, B.
    [J]. DIABETIC MEDICINE, 2013, 30 : 74 - 74
  • [4] Health status and hypoglycaemia with insulin degludec versus insulin glargine: a 2-year trial in insulin-naive patients with type 2 diabetes
    Rodbard, H. W.
    Cariou, B.
    Zinman, B.
    Handelsman, Y.
    Wolden, M. L.
    Rana, A.
    Mathieu, C.
    [J]. DIABETES OBESITY & METABOLISM, 2014, 16 (09): : 869 - 872
  • [5] Effect of insulin degludec on glycaemic control and nocturnal hypoglycaemia compared with insulin glargine: a 1-year trial in insulin-naive patients with type 2 diabetes
    Zinman, B.
    Philis-Tsimikas, A.
    Handelsman, Y.
    Rodbard, H. W.
    Cariou, B.
    Johansen, T.
    Endahl, L.
    Mathieu, C.
    [J]. DIABETOLOGIA, 2012, 55 : S22 - S22
  • [6] Physical Health Status and Nocturnal Hypoglycemia With Insulin Degludec vs. Insulin Glargine: A 2-Year Trial in Insulin-Naive Patients With Type 2 Diabetes
    Rodbard, Helena W.
    Cariou, Bertrand
    Zinman, Bernard
    Han-Delsman, Yehuda
    Wolden, Michael L.
    Rana, Azhar
    Mathieu, Chantal
    [J]. DIABETES, 2013, 62 : A237 - A238
  • [7] Insulin degludec vs. Insulin glargine 100 U/ml in diabetes: 2-year results
    Siegmund, T.
    Westrup, D.
    [J]. DIABETES STOFFWECHSEL UND HERZ, 2017, 26 (01): : 21 - 28
  • [8] Ultra-long-acting insulin degludec shown to reduce the risk of nocturnal hypoglycaemia compared to insulin glargine in patients with type 1 and type 2 diabetes
    Idris, Iskandar
    [J]. DIABETES OBESITY & METABOLISM, 2012, 14 (07): : 673 - 673
  • [9] Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial
    Rodbard, H. W.
    Cariou, B.
    Zinman, B.
    Handelsman, Y.
    Philis-Tsimikas, A.
    Skjoth, T. V.
    Rana, A.
    Mathieu, C.
    [J]. DIABETIC MEDICINE, 2013, 30 (11) : 1298 - 1304
  • [10] Improved glycaemic control and reduced nocturnal hypoglycaemia in patients with Type 2 diabetes with morning administration of insulin glargine compared with NPH insulin
    Fritsche, A
    Schweitzer, MA
    Häring, H
    [J]. DIABETOLOGIA, 2002, 45 : A52 - A52
12345